Early data presented by Cassava Sciences demonstrates the safety of their Alzheimer’s drug simufilam, which is currently in Phase 3 clinical trials. But in late…
Alzheimer’s is a complex disease, and studies that follow participants over extended periods of time can gather troves of data on the progression of…
University of Montreal neuropsychology PhD student Émilie Delage, University of Quebec at Montreal professor of psychology and neuropsychology Isabelle Rouleau and University of Montreal…
Bad news arrived recently for the constantly caffeinated: Researchers recently found evidence that drinking more than six cups of coffee a day could shrink…
IMAGE: Photobiomodulation tabletop device Beacon40 by neurotechnology company Bright Could flickering lights have brain health benefits? Research around experimental therapies involving external stimuli —…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. IMAGE: Sherita Jenkins and her mother Bettye,…
The human body is host to trillions of microscopic organisms — collectively called the microbiome — that shape our health across the lifespan. This…
A recent cell study shows that experimental Parkinson’s and Alzheimer’s antibodies may trigger harmful brain inflammation—which could explain clinical trials’ dismal failure rates. In…
The biotechnology company Cassava Sciences — makers of simufilam, an anti-Alzheimer’s drug currently in Phase III clinical trials — was accused of scientific misconduct…
In villages dotted across the Amazon rainforest in the Bolivian lowlands, roughly 16,000 Tsimane people subsist largely by farming, fishing, hunting and foraging. The…
A recent analysis reveals that people with Alzheimer’s taking Alzheimer’s drug galantamine (Razadyne), approved nearly two decades ago, show moderate cognitive benefits as well…
Whether it be coping with the cognitive, behavioral or psychological symptoms of dementia, adapting caregiver strategies throughout the different stages of the illness is…
Bryan Johnson, CEO of neuroscience start-up Kernel, wants to put a ‘helmet in every household.’ Could Kernel’s wearable, sensor-loaded brain monitoring device be the…
Caregiving expert Teepa Snow knows from experience: There isn’t a one-size-fits-all approach to guide caregivers of people with Alzheimer’s or related dementias. In her…
Scientists in the field of Alzheimer’s have struggled to carry promising findings in mice studies into human trials, but primate researchers believe that animals…